Yazid Daci is currently the Responsable Grands Comptes (RGC) for rare cardiovascular diseases at Bayer, a position held since 2023. Previously, Yazid served as a Spécialiste parcours de soin in Ophtalmology/Cardio-Renal at Bayer and worked as an Attaché scientifique at Ethypharm from 2020 to 2023. Yazid's earlier experience includes roles as a Préparateur pharmacie at Grande Pharmacie de Paris Roubaix from 2008 to 2010 and as a Visiteur médical and Visiteur hospitalier at Bayer Pharmaceuticals from 2018 to 2020. Yazid studied medical visiting in the pharmaceutical industry at ILIS Faculte Ingenierie et management de la Sante in 2011 and completed training as a Pharmacy technician at ARCPP Villeneuve D'Ascq in 2010.
This person is not in the org chart
This person is not in any teams
This person is not in any offices